Multiple Choice
What can be done to prevent the development of HLA alloimmunization and platelet refractoriness?
A) Test the donor for the presence of platelet antibodies.
B) Issue only cytomegalovirus-negative platelets.
C) Irradiate the platelet concentrate.
D) Reduce the number of leukocytes in the platelet product.
Correct Answer:
Verified
Correct Answer:
Verified
Q19: How is HES used in apheresis procedures?<br>A)
Q20: Which apheresis method carries the additional risk
Q21: Which immunoadsorbent has an affinity for IgG
Q22: Plasma exchange is most effective when is
Q23: All of the following statements are consistent
Q25: When is isolation of PBSCs via apheresis
Q26: Currently, the immunoaffinity column has FDA licensure
Q27: In what circumstance is a plasmapheresis donor
Q28: Photopheresis is effective against what malignant disorder?<br>A)
Q29: Which of the following statements best describes